M3 Inc
Free Cash Flow

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

M3 Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
M3 Inc
TSE:2413
Free Cash Flow
¥42.8B
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
18%
EM Systems Co Ltd
TSE:4820
Free Cash Flow
¥4.3B
CAGR 3-Years
36%
CAGR 5-Years
30%
CAGR 10-Years
13%
S
Software Service Inc
TSE:3733
Free Cash Flow
¥5.2B
CAGR 3-Years
49%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medley Inc
TSE:4480
Free Cash Flow
¥2.2B
CAGR 3-Years
39%
CAGR 5-Years
44%
CAGR 10-Years
N/A
CareNet Inc
TSE:2150
Free Cash Flow
¥2B
CAGR 3-Years
15%
CAGR 5-Years
31%
CAGR 10-Years
21%
JMDC Inc
TSE:4483
Free Cash Flow
¥8.1B
CAGR 3-Years
61%
CAGR 5-Years
188%
CAGR 10-Years
N/A
No Stocks Found

M3 Inc
Glance View

M3 Inc. emerged from Japan in the late 1990s, rapidly morphing from a novel digital venture into a formidable player in the global medical information services arena. The company's genesis was rooted in the transformative vision of leveraging web-based platforms to bridge vast distances between healthcare professionals, providing them with timely, accurate information and resources. As the internet began revolutionizing industries, M3 Inc. seized this opportunity, focusing on creating a seamless digital environment that connected pharmaceutical companies with medical professionals. Their flagship offering, M3.com, became a pivotal platform—essentially serving as a nexus where healthcare giants could introduce their latest products and innovations to an audience of medical practitioners, facilitating informed decision-making and nurturing vital industry relationships. Reaching beyond Japanese shores, M3 Inc. strategically expanded its influence into markets in Europe, the United States, and further afield, deftly tailoring its platforms to meet diverse regulatory standards and cultural nuances. Today, its financial vitality is driven by a multifaceted business model. Primarily, M3 derives revenue from pharmaceutical companies and medical device makers who pay for advertising space and market research insights on its network, valuing the direct engagement with physicians it facilitates. Moreover, the company has smartly diversified its portfolio by incorporating online healthcare services and physician recruitment, offering a comprehensive suite of services that cater to the evolving needs of the medical community. By aligning its growth with the digital evolution of the healthcare industry, M3 Inc. continues to solidify its role as a linchpin in the health information ecosystem.

M3 Inc Intrinsic Value
HIDDEN
Show

See Also

What is M3 Inc's Free Cash Flow?
Free Cash Flow
42.8B JPY

Based on the financial report for Jun 30, 2025, M3 Inc's Free Cash Flow amounts to 42.8B JPY.

What is M3 Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
18%

Over the last year, the Free Cash Flow growth was -16%. The average annual Free Cash Flow growth rates for M3 Inc have been -5% over the past three years , 10% over the past five years , and 18% over the past ten years .

Back to Top